Grape King Bio Ltd (1707) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.097x

Based on the latest financial reports, Grape King Bio Ltd (1707) has a cash flow conversion efficiency ratio of 0.097x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$1.17 Billion ≈ $36.92 Million USD) by net assets (NT$12.07 Billion ≈ $380.16 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how leveraged is Grape King Bio Ltd's balance sheet to measure how much of total assets are equity-financed.

Grape King Bio Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Grape King Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 1707 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Grape King Bio Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Grape King Bio Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Universal Logistics Holdings Inc NASDAQ:ULH	0.045x
Morguard North American Residential Real Estate Investment Trust TO:MRG-UN	0.008x
Shanghai ZJ Bio-Tech Co. Ltd. A SHG:688317	0.002x
Zinwell Corporation TW:2485	-0.022x
Rolex Rings Limited NSE:ROLEXRINGS	0.075x
EVS Broadcast Equipment SA BR:EVS	-0.014x
Zhanjiang Guolian Aquatic Products SHE:300094	0.014x
Jiangxi Chen Guang New Materials Co Ltd SHG:605399	-0.014x

Annual Cash Flow Conversion Efficiency for Grape King Bio Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Grape King Bio Ltd from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see 1707 market cap overview.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$12.07 Billion ≈ $380.16 Million	NT$2.18 Billion ≈ $68.68 Million	0.181x	+13.55%
2024-12-31	NT$11.79 Billion ≈ $371.47 Million	NT$1.88 Billion ≈ $59.10 Million	0.159x	-26.56%
2023-12-31	NT$11.63 Billion ≈ $366.41 Million	NT$2.52 Billion ≈ $79.37 Million	0.217x	-19.29%
2022-12-31	NT$11.14 Billion ≈ $351.00 Million	NT$2.99 Billion ≈ $94.22 Million	0.268x	+10.12%
2021-12-31	NT$10.43 Billion ≈ $328.58 Million	NT$2.54 Billion ≈ $80.09 Million	0.244x	-28.48%
2020-12-31	NT$7.98 Billion ≈ $251.37 Million	NT$2.72 Billion ≈ $85.67 Million	0.341x	+17.26%
2019-12-31	NT$7.47 Billion ≈ $235.37 Million	NT$2.17 Billion ≈ $68.41 Million	0.291x	-16.64%
2018-12-31	NT$6.93 Billion ≈ $218.44 Million	NT$2.42 Billion ≈ $76.16 Million	0.349x	-11.59%
2017-12-31	NT$6.33 Billion ≈ $199.37 Million	NT$2.50 Billion ≈ $78.63 Million	0.394x	-18.64%
2016-12-31	NT$5.78 Billion ≈ $182.19 Million	NT$2.80 Billion ≈ $88.31 Million	0.485x	+56.50%
2015-12-31	NT$4.22 Billion ≈ $132.94 Million	NT$1.31 Billion ≈ $41.18 Million	0.310x	-32.34%
2014-12-31	NT$3.72 Billion ≈ $117.10 Million	NT$1.70 Billion ≈ $53.60 Million	0.458x	-6.43%
2013-12-31	NT$3.22 Billion ≈ $101.47 Million	NT$1.58 Billion ≈ $49.65 Million	0.489x	+19.64%
2012-12-31	NT$2.74 Billion ≈ $86.39 Million	NT$1.12 Billion ≈ $35.33 Million	0.409x	+19.10%
2011-12-31	NT$2.47 Billion ≈ $77.86 Million	NT$848.53 Million ≈ $26.73 Million	0.343x	+13.46%
2010-12-31	NT$2.26 Billion ≈ $71.20 Million	NT$683.89 Million ≈ $21.55 Million	0.303x	-12.82%
2009-12-31	NT$2.08 Billion ≈ $65.40 Million	NT$720.61 Million ≈ $22.70 Million	0.347x	+39.24%
2008-12-31	NT$1.74 Billion ≈ $54.95 Million	NT$434.85 Million ≈ $13.70 Million	0.249x	+74.65%
2007-12-31	NT$1.77 Billion ≈ $55.86 Million	NT$253.11 Million ≈ $7.97 Million	0.143x	-48.28%
2006-12-31	NT$1.70 Billion ≈ $53.52 Million	NT$468.84 Million ≈ $14.77 Million	0.276x	+26.09%
2005-12-31	NT$1.60 Billion ≈ $50.42 Million	NT$350.26 Million ≈ $11.04 Million	0.219x	+597.83%
2004-12-31	NT$1.58 Billion ≈ $49.75 Million	NT$49.53 Million ≈ $1.56 Million	0.031x	-65.88%
2003-12-31	NT$1.48 Billion ≈ $46.75 Million	NT$136.42 Million ≈ $4.30 Million	0.092x	+75.77%
2002-12-31	NT$1.46 Billion ≈ $46.03 Million	NT$76.42 Million ≈ $2.41 Million	0.052x	--

About Grape King Bio Ltd

TW:1707 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$422.84 Million

NT$13.42 Billion TWD

Market Cap Rank

#12839 Global

#511 in Taiwan

Share Price

NT$90.60

Change (1 day)

-0.88%

52-Week Range

NT$90.60 - NT$136.00

All Time High

NT$227.99